Related references
Note: Only part of the references are listed.Rocaglamide breaks TRAIL resistance in HTLV-1-associated adult T-cell leukemia/lymphoma by translational suppression of c-FLIP expression
M. Bleumink et al.
CELL DEATH AND DIFFERENTIATION (2011)
Identification of c-FLIPL and c-FLIPS as critical regulators of death receptor-induced apoptosis in pancreatic cancer cells
Christian Haag et al.
GUT (2011)
Emerging drugs for Hodgkin's lymphoma
Boris Boell et al.
EXPERT OPINION ON EMERGING DRUGS (2010)
Cell death in hematological tumors
Simone Fulda
APOPTOSIS (2009)
Small molecule XIAP inhibitors cooperate with TRAIL to induce apoptosis in childhood acute leukemia cells and overcome Bcl-2-mediated resistance
Melanie Fakler et al.
BLOOD (2009)
Small Molecule XIAP Inhibitors Enhance TRAIL-Induced Apoptosis and Antitumor Activity in Preclinical Models of Pancreatic Carcinoma
Meike Vogler et al.
CANCER RESEARCH (2009)
Rocaglamide sensitizes leukemic T cells to activation-induced cell death by differential regulation of CD95L and c-FLIP expression
J. Y. Zhu et al.
CELL DEATH AND DIFFERENTIATION (2009)
IAP-targeted therapies for cancer
E. C. LaCasse et al.
ONCOGENE (2008)
The TRAIL apoptotic pathway in cancer onset, progression and therapy
Ricky W. Johnstone et al.
NATURE REVIEWS CANCER (2008)
The traditional Chinese herbal compound rocaglamide preferentially induces apoptosis in leukemia cells by modulation of mitogen-activated protein kinase activities
Jia Y. Zhu et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Life and death in peripheral T cells
Peter H. Krammer et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin lymphomas
Nalan Akyurek et al.
CANCER (2006)
The E3 ubiquitin ligase itch couples JNK activation to TNFα-induced cell death by inducing c-FLIPL turnover
LF Chang et al.
CELL (2006)
Rapid turnover of c-FLIP short is determined by its unique C-terminal tail
M Poukkula et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential
D Re et al.
BLOOD (2005)
Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death
A Dutton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis
S Mathas et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer
TK Oost et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival
B Zheng et al.
BLOOD (2003)
XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells
H Kashkar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Notch3 signaling in vascular smooth muscle cells induces c-FLIP expression via ERK/MAPK activation - Resistance to Fas ligand-induced apoptosis
WL Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
IAP proteins: Blocking the road to death's door
GS Salvesen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions
D Lawrence et al.
NATURE MEDICINE (2001)
Share Paper
